Member Info for draft

https://www.mirror.co.uk/money/sainsburys-payroll-hit-cyber-attack-25721936

https://www.mirror.co.uk/money/sainsburys-payroll-hit-cyber-attack-25721936

https://www.mirror.co.uk/money/sainsburys-payroll-hit-cyber-attack-25721936

man these things arent translating to damn sales, we just need Agropur to make an offer , ill take 60p and walk quite frankly,

boy what a mess.

anyway no point commenting on more given its suspended at the moment.

dissapointing,. 4p i would have thought was reasonble but to price at 2p is atrocious

a disaster of an arrangmeent and placing, absolute pants. Im going to be massively down when this comes back and as i dont do averaging do certainly dont expect me to buy any more,. garbage price, wtf are these pricks thinking.

3 of the turbines are still NOT in the water

SAE continues to work on the re-deployment of the three turbines, out the water for maintenance, at phase 1 of MeyGen. The re-deployment of one of the turbines was set back following a crane failure on the vessel being used for its re-deployment. SAE is working with the vessel operator to determine the next appropriate time for deployment. SAE is working with stakeholders to ensure the remaining two turbines can return to operation as quickly as possible. The operational fourth turbine continues to exceed expectations and demonstrates the viability of tidal turbine technology

https://www.express.co.uk/news/world/1536894/australia-ransomware-data-attack-last-news-ont

https://portswigger.net/daily-swig/propane-distributor-superior-plus-admits-ransomware-breach

https://www.coindesk.com/business/2021/12/15/crowdsourced-threat-detector-polyswarm-goes-live-on-mainnet/

Professor John Martin, chairman of St George Street Capital, said the completion of the report from the clinical study was a major milestone: "We are encouraged by the trial findings which indicate that AZD1656, a simple oral tablet, has the potential to become a new treatment for COVID-19 - independent of viral mutations - initiating a new wave of therapies for clinicians in meeting this global challenge."

James Normand, director of Vela, said: "The board of Vela is delighted to be informed of this significant development in what is the company's most material investment. We note that St George Street is now moving forward with the proposed commercialisation of the AZ1656 drug and we look forward to positive news on this process in the near future."

this could go flying up on a commercial deal then

with all the fraud and cyber attacks going on, how is this not higher, will be soon i reckon

Deltic Energy chief executive Graham Swindells said: “We are delighted with the progress we have made this year and excited by what next year will bring. We are a relatively small, exploration and production-focused company which has punched way above its weight, to secure partners like Shell and Cairn. Most people recognise that domestic oil and gas production is good for jobs, the economy, and the environment. We remain committed as a company and an industry to deliver the net-zero carbon plan and we have a key role to play, as the government says. There are still huge opportunities in the North Sea.

“Earlier this year our industry signed a landmark agreement with the government, the North Sea Transition Deal, under which we promised secure supplies of energy alongside a move to ever-lower carbon emissions. We are delivering on that promise.”

Verifiable Credentials, Crossword Cybersecurity plc and East Kent Hospitals University NHS Foundation Trust to work on Covid-19 Certificates Trial

10 November 2020 - London, UK - Crossword Cybersecurity Plc (AIM:CCS, "Crossword", the "Company" or the "Group"), the technology commercialisation company focused solely on cyber security and risk, is pleased to announced that it will be working with Verifiable Credentials Ltd (VCL) and East Kent Hospitals University NHS Foundation Trust on a "proof of concept" trial using VCL's verifiable credentials application independent middleware. InnovateUK have awarded funding to support the trial to create a local system that allows NHS testing laboratories in East Kent to issue Covid-19 immunity certificates to individuals to hold securely on their smartphones, and for selected organisations to check the validity of those certificates when presented to them wherever they are, without compromising any unnecessary personal information.

VCL issued the following statement:

"We're all looking forward to the day when a Covid-19 vaccinations are available to everyone, in order to save lives and get life back to normal. But it won't be an instant process and there will be a potentially long period during which people will sometimes need to prove (for example, to employers and public or hospitality industry venue managers) that they have either received a vaccination, or been positively tested for antibodies from a previous infection.

It's hugely important that such certification is secure, trust-worthy and verifiable by those who need to check them at places of work, or hospitality venues. It must above all ensure the privacy of the individual certificate holder and allow them to prove immunity, without compromising other personal data such as their date-of-birth, or home address.

For this reason, Verifiable Credentials Ltd (VCL), East Kent Hospitals University NHS Foundation Trust and Crossword Cybersecurity plc (Crossword) have been awarded InnovateUK funding to conduct a "proof of concept" trial using VCL's application independent Identiproof middleware.

Together they will create a local system that allows NHS testing laboratories in East Kent to issue Covid-19 certificates to individuals to hold securely on their smartphones, and for selected organisations to check the validity of those certificates when presented to them wherever they are, without compromising any unnecessary personal information. VCL and Crossword will lead the work on the longer-term commercialisation of the system demonstrated during the trial."

Identiproof is a Zero Trust Architecture, being an implementation of the W3C Verifiable Credentials Data Model, together with VCL's own W3C Web Authentication (FIDO2) compatible protocol.



An East Kent Hospitals University NHS Foundation Trust spokesperson said: "This is a good example of local innovators working with local NHS organisations to develop innovative ideas. Bei

we know Identiproof were trialling these.

FYI Cenkos have a new eight page Buy note out this morning. Worth highlighting in particular: "Highly Repeatable Economics – Getech estimates that the Inverness green hydrogen hub will have the capacity to scale up to 8 tonnes of hydrogen per day. Similar to the Shoreham hub, we estimate that the build time to first hydrogen will be c18 months from FID. The Inverness hub follows H2 Green’s asset model of structuring its hydrogen operations around a holding company, with multiple site-specific operating companies. Capital investment will be raised at the operating company level, with the Group targeting funds from entities including strategic investors, infrastructure funds and government. The land value of the Inverness hub has been agreed with SGN and priced at a pre - development market cost, payable in cash or project equity. SGN has also been granted an option to scale its equity interest in the project – providing the framework for SGN to become a strategic partner/investor." "Modelling a mid -sized 8 tonne per day facility, in which H2 Green retains a 20% project interest, this generates an annual revenue of £4.7m and an EBITDA of £1.7m net to H2 Green. If Getech were to achieve a full carry on the initial capital investment, this EBITDA would fall straight to the bottom line as cash (pre-tax). Projecting this EBITDA stream across a 30-year asset life, it equates to a single asset NPV10 of c£10.4m net to Getech."

crossword cybersecurity had a Identiproof covid cert kind of thing

looking good guys,

- the virus
- more lockdowns
- debt
- litigation

ive taken a loss now, even if they appeal it is not going to be an amazing result.